- Home
- CRAI vs MNKD Comparison
CRAI vs MNKD Comparison
Compare CRAI & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRAI
- MNKD
- Stock Information
- Founded
- CRAI 1965
- MNKD 1991
- Country
- CRAI United States
- MNKD United States
- Employees
- CRAI N/A
- MNKD N/A
- Industry
- CRAI Other Consumer Services
- MNKD Biotechnology: Pharmaceutical Preparations
- Sector
- CRAI Consumer Discretionary
- MNKD Health Care
- Exchange
- CRAI Nasdaq
- MNKD Nasdaq
- Market Cap
- CRAI 1.2B
- MNKD 1.2B
- IPO Year
- CRAI 1998
- MNKD 2004
- Fundamental
- Price
- CRAI $197.15
- MNKD $4.11
- Analyst Decision
- CRAI Buy
- MNKD Buy
- Analyst Count
- CRAI 1
- MNKD 6
- Target Price
- CRAI $228.00
- MNKD $9.17
- AVG Volume (30 Days)
- CRAI 80.3K
- MNKD 3.2M
- Earning Date
- CRAI 07-31-2025
- MNKD 08-06-2025
- Dividend Yield
- CRAI 1.02%
- MNKD N/A
- EPS Growth
- CRAI 44.21
- MNKD 149.32
- EPS
- CRAI 8.27
- MNKD 0.11
- Revenue
- CRAI $712,913,000.00
- MNKD $301,736,000.00
- Revenue This Year
- CRAI $7.47
- MNKD $13.62
- Revenue Next Year
- CRAI $4.48
- MNKD $15.18
- P/E Ratio
- CRAI $23.85
- MNKD $37.98
- Revenue Growth
- CRAI 9.28
- MNKD 21.48
- 52 Week Low
- CRAI $152.57
- MNKD $3.38
- 52 Week High
- CRAI $214.01
- MNKD $7.63
- Technical
- Relative Strength Index (RSI)
- CRAI 63.32
- MNKD 60.67
- Support Level
- CRAI $183.75
- MNKD $3.60
- Resistance Level
- CRAI $193.68
- MNKD $3.99
- Average True Range (ATR)
- CRAI 6.09
- MNKD 0.15
- MACD
- CRAI 1.28
- MNKD 0.05
- Stochastic Oscillator
- CRAI 83.91
- MNKD 98.65
About CRAI CRA International Inc.
CRA International Inc is a U.S.-based advisory firm that provides economic, financial, and management consultancy services. The company advises clients on economic and financial issues relating to litigation and regulatory proceedings and helps businesses set important business strategies and solve performance-related issues. The company's clients include domestic and foreign companies, government agencies, public and private utilities, and national and international trade associations. CRA International generates majority of its revenue from the United States, while it also has its presence in United Kingdom and Other Countries.
About MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.